Valuation: Qlife Holding AB

Market Cap 54.86M 5.66M 4.97M 4.62M 4.25M 7.97M 541M 8.11M 21.47M 268M 21.24M 20.78M 926M P/E 2024
-0.26x
P/E 2025 -1.73x
Enterprise Value 67.88M 7M 6.14M 5.72M 5.26M 9.87M 669M 10.03M 26.57M 332M 26.29M 25.72M 1.15B EV / Sales 2024
222x
EV / Sales 2025 178x
Free-Float
60.05%
Yield 2024 *
-
Yield 2025 -
1 week-1.35%
Current month-5.00%
1 month-1.55%
3 months+0.74%
6 months-2.31%
Current year-33.10%
1 week 1.79
Extreme 1.794
2.04
1 month 1.7
Extreme 1.7
2.04
Current year 1.7
Extreme 1.7
3.09
1 year 1.2
Extreme 1.205
4.93
3 years 1.2
Extreme 1.205
179
5 years 1.2
Extreme 1.205
101,600
10 years 1.2
Extreme 1.205
120,000
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2019
Chief Executive Officer 59 11/10/2019
Director of Finance/CFO 60 01/11/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2021
Director/Board Member 52 01/01/2023
Chairman 61 21/03/2025
Date Insider Type Main position Quantity % Market Cap.
6/14/23 A
Qlife ApS
OthersCompany 40,630,656 6.7731%
6/14/23 A Free

Chief Executive Officer

12,697,080 2.1166%
6/13/23 A Free

Chief Financial Officer

5,078,832 0.8466%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.35%-52.02%-98.22% 5.66M
+1.58%+8.58%-14.69%-1.91% 187B
+0.94%+7.21%-5.03%+0.04% 111B
-0.04%+6.41%+10.38%+71.14% 62.18B
+0.34%-5.11%+24.82%+43.77% 48.4B
+1.34%+9.73%-7.85%-39.68% 45.83B
+0.21%+9.97% - - 34.26B
+0.15%+5.74%-15.47%-39.36% 28.88B
-0.52%-6.54%+32.42%-8.99% 23.72B
+1.42%+11.25%+2.58%+3.86% 22.45B
Average +0.63%+1.14%-2.76%-7.71% 56.38B
Weighted average by Cap. +0.99%+3.89%-2.72%+5.87%

Financials

2024 2025
Net sales 50K 5.16K 4.53K 4.21K 3.88K 7.27K 493K 7.39K 19.57K 244K 19.36K 18.94K 844K 324K 33.42K 29.33K 27.31K 25.12K 47.09K 3.19M 47.89K 127K 1.58M 125K 123K 5.47M
Net income -55.92M -5.77M -5.06M -4.71M -4.34M -8.13M -551M -8.27M -21.89M -273M -21.65M -21.18M -944M -20.56M -2.12M -1.86M -1.73M -1.59M -2.99M -203M -3.04M -8.05M -100M -7.96M -7.79M -347M
Net Debt 5.98M 617K 542K 504K 464K 870K 58.97M 885K 2.34M 29.24M 2.32M 2.27M 101M 13.02M 1.34M 1.18M 1.1M 1.01M 1.89M 128M 1.93M 5.1M 63.64M 5.04M 4.93M 220M
Logo Qlife Holding AB
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Employees
3
Date Price Change Volume
29/07/26 SEK 1.900 0.00% 9,543
28/07/26 SEK 1.900 -4.43% 100,764
27/07/26 SEK 1.988 +2.47% 30,082
24/07/26 SEK 1.940 +1.04% 38,385
23/07/26 SEK 1.920 -0.31% 13,826

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QLIFE Stock